Microvascular Dysfunction in Adults with Congenital Heart Disease and the Effect of Exercise Training
MICONEX
1 other identifier
interventional
55
1 country
1
Brief Summary
The goal of this prospective cohort study is to deepen the understanding of the pathophysiology in adults with congenital heart disease (CHD). Through this research, the investigators aim to identify potential strategies to improve the prevention and treatment of these patients. In this context, the effects of exercise training will also be assessed. The main questions it aims to answer are:
- Is coronary microvascular dysfunction (MVD) present in adults with diverse types of CHD?
- Is peripheral MVD present in adults with diverse types of CHD?
- Are coronary and peripheral MVD correlated in adults with diverse types of CHD?
- Is microvascular function correlated with inflammation and oxidative stress in adults with diverse types of CHD?
- Are inflammation and oxidative stress correlated with ventricular function in adults with diverse types of CHD?
- Are MVD and diminished ventricular function interrelated and associated with reduced exercise capacity in adults with diverse types of CHD?
- Does exercise training in adults with CHD result in improvements in coronary and peripheral microvascular function, inflammation and oxidative stress, biventricular function, muscle strength, exercise capacity and quality of life? For the last research question, patients were randomized to receive either conventional care or home-based aerobic and strength exercise training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2024
CompletedFirst Submitted
Initial submission to the registry
November 26, 2024
CompletedFirst Posted
Study publicly available on registry
December 4, 2024
CompletedDecember 4, 2024
November 1, 2024
3.2 years
November 26, 2024
December 2, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Coronary microvascular function: coronary flow reserve
The coronary flow reserve (CFR) was measured using pulsed wave Doppler measurements at the mid to distal left anterior descending artery (LAD) in an apical modified 2-chamber view. At baseline and during hyperemia (following a 3-minute period of intravenous adenosine administration at a rate of 140 µg/kg/min), three optimal profiles of peak diastolic Doppler flow velocities were measured, and the results were averaged. CFR was then calculated as the ratio between hyperemic and basal average peak velocities.
on both study visits (at baseline and at 16 weeks)
Secondary Outcomes (18)
Peripheral microvascular function: reactive hyperemia index
on both study visits (at baseline and at 16 weeks)
Peripheral microvascular function: Framingham modified reactive hyperemia index
on both study visits (at baseline and at 16 weeks)
Carotid arterial wall thickness: carotid intima-media thickness
on both study visits (at baseline and at 16 weeks)
Large artery stiffness: pulse wave velocity
on both study visits (at baseline and at 16 weeks)
Large artery stiffness: augmentation index
on both study visits (at baseline and at 16 weeks)
- +13 more secondary outcomes
Study Arms (2)
Exercise arm
EXPERIMENTALEach participant received a personalized rehabilitation schedule combining aerobic interval cycle training and a dynamic strength exercise program, developed to ensure that the participants met the physical activity guidelines.
Conventional care arm
NO INTERVENTIONIn the conventional care arm, patients did not receive explicit exercise advice but were provided with general information regarding a healthy lifestyle, in accordance with current physical activity guidelines during the first study visit.
Interventions
Each participant received a personalized rehabilitation schedule combining aerobic interval cycle training and a dynamic strength exercise program, developed to ensure that the participants met the physical activity guidelines. For the aerobic training, the patients cycled for 30-45 minutes on an exercise bike at home 3 times a week. During each training session, the heart rate (HR) was continuously recorded using a chest strap and displayed in a smartphone application. The target HR zones were predefined with alternating intervals of intensive and extensive aerobic training. The program followed a progressive structure with the objective of completing 40 minutes of intensive aerobic training after 16 weeks. In the strength training program, 4 dynamic exercises targeting major muscle groups were performed 3 times a week. Every 2 weeks, these exercises were intensified by altering the starting position or adding extra weight.
Eligibility Criteria
You may qualify if:
- adults with congenital heart disease: as many different types of CHD as possible were incorporated
- New York Heart Association (NYHA) class I-II
- who visited the out-patient clinic at the Antwerp University Hospital
You may not qualify if:
- smoking
- body mass index \>35 kg/m²
- professional endurance athlete
- the presence of macrovascular coronary artery disease
- diabetes mellitus
- a systemic disease (e.g., malignancies, acute and chronic inflammatory diseases in the preceding 3 months)
- a contraindication for adenosine administration.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Antwerp University Hospital
Edegem, Antwerp, 2650, Belgium
Related Publications (5)
Vanreusel I, Vermeulen D, Goovaerts I, Stoop T, Ectors B, Cornelis J, Hens W, de Bliek E, Heuten H, Van Craenenbroeck EM, Van Berendoncks A, Segers VFM, Briede JJ. Circulating Reactive Oxygen Species in Adults with Congenital Heart Disease. Antioxidants (Basel). 2022 Nov 30;11(12):2369. doi: 10.3390/antiox11122369.
PMID: 36552576BACKGROUNDVanreusel I, Taeymans J, Van Craenenbroeck E, Segers VFM, Van Berendoncks A, Briedé JJ, et al. Oxidative Stress in Patients with Congenital Heart Disease: A Systematic Review. Advances in Redox Research. 2024:100109
BACKGROUNDVanreusel I, Taeymans J, Van Craenenbroeck E, Segers VFM, Van Berendoncks A, Briede JJ, Hens W. Elevated oxidative stress in patients with congenital heart disease and the effect of cyanosis: a meta-analysis. Free Radic Res. 2023 May-Jun;57(6-12):470-486. doi: 10.1080/10715762.2023.2284639. Epub 2023 Dec 26.
PMID: 38000042BACKGROUNDVanreusel I, Hens W, Van Craenenbroeck E, Van Berendoncks A, Segers VFM. Peripheral Microvascular Dysfunction in Children and Adults with Congenital Heart Disease: A Literature Review. Curr Cardiol Rev. 2024;20(4):e210224227260. doi: 10.2174/011573403X278440240209064408.
PMID: 38409710BACKGROUNDVanreusel I, Segers VFM, Craenenbroeck EV, Berendoncks AV. Coronary Microvascular Dysfunction in Patients with Congenital Heart Disease. Curr Cardiol Rev. 2023;19(4):e190123212886. doi: 10.2174/1573403X19666230119112634.
PMID: 36658708BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2024
First Posted
December 4, 2024
Study Start
January 18, 2021
Primary Completion
March 31, 2024
Study Completion
May 31, 2024
Last Updated
December 4, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share